• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AGEs 及其受体 RAGE 在神经退行性变中的作用和治疗潜力。

Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.

机构信息

Department of Medicine, Division of Geriatrics and Gerontology, University of Wisconsin- Madison, Madison, WI, USA.

Geriatric Research Education Clinical Center, Veterans Affairs Medical Center, Madison, WI, USA.

出版信息

Curr Drug Targets. 2022;23(12):1191-1209. doi: 10.2174/1389450123666220610171005.

DOI:10.2174/1389450123666220610171005
PMID:35702767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9589927/
Abstract

Activation of the receptor for advanced glycation end products (RAGE) has been shown to play an active role in the development of multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis. Although originally identified as a receptor for advanced glycation end products, RAGE is a pattern recognition receptor able to bind multiple ligands. The final outcome of RAGE signaling is defined in a context and cell type specific manner and can exert both neurotoxic and neuroprotective functions. Contributing to the complexity of the RAGE signaling network, different RAGE isoforms with distinctive signaling capabilities have been described. Moreover, multiple RAGE ligands bind other receptors and RAGE antagonism can significantly affect their signaling. Here, we discuss the outcome of celltype specific RAGE signaling in neurodegenerative pathologies. In addition, we will review the different approaches that have been developed to target RAGE signaling and their therapeutic potential. A clear understanding of the outcome of RAGE signaling in a cell type- and disease-specific manner would contribute to advancing the development of new therapies targeting RAGE. The ability to counteract RAGE neurotoxic signaling while preserving its neuroprotective effects would be critical for the success of novel therapies targeting RAGE signaling.

摘要

晚期糖基化终产物受体(RAGE)的激活已被证明在多种神经退行性疾病的发展中发挥着积极作用,包括阿尔茨海默病、帕金森病和肌萎缩侧索硬化症。尽管 RAGE 最初被鉴定为晚期糖基化终产物的受体,但它是一种模式识别受体,能够结合多种配体。RAGE 信号的最终结果是特定于上下文和细胞类型的,并可以发挥神经毒性和神经保护作用。RAGE 信号网络的复杂性导致了具有不同信号转导能力的不同 RAGE 异构体的描述。此外,多种 RAGE 配体与其他受体结合,RAGE 拮抗作用可显著影响它们的信号转导。在这里,我们讨论了特定于细胞类型的 RAGE 信号在神经退行性病理中的结果。此外,我们将回顾为靶向 RAGE 信号而开发的不同方法及其治疗潜力。明确了解 RAGE 信号在细胞类型和疾病特异性方面的结果将有助于推进针对 RAGE 的新疗法的发展。在保留其神经保护作用的同时拮抗 RAGE 神经毒性信号的能力对于针对 RAGE 信号的新型治疗方法的成功至关重要。

相似文献

1
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.AGEs 及其受体 RAGE 在神经退行性变中的作用和治疗潜力。
Curr Drug Targets. 2022;23(12):1191-1209. doi: 10.2174/1389450123666220610171005.
2
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.晚期糖基化终产物受体(RAGE):针对神经退行性疾病治疗的有前途的靶点。
Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.
3
RAGE and its ligands: from pathogenesis to therapeutics.晚期糖基化终产物受体及其配体:从发病机制到治疗学。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):555-575. doi: 10.1080/10409238.2020.1819194. Epub 2020 Sep 16.
4
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.靶向晚期糖基化终产物受体(RAGE)的小分子抑制剂的治疗潜力。
Drug Dev Res. 2022 Sep;83(6):1257-1269. doi: 10.1002/ddr.21971. Epub 2022 Jul 4.
5
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.晚期糖基化终产物受体(RAGE):免疫疾病的关键枢纽。
Molecules. 2022 Aug 2;27(15):4922. doi: 10.3390/molecules27154922.
6
The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system.晚期糖基化终产物受体(RAGE)和 DIAPH1:在中枢神经系统疾病中的血管和神经炎症功能障碍的意义。
Neurochem Int. 2019 Jun;126:154-164. doi: 10.1016/j.neuint.2019.03.012. Epub 2019 Mar 20.
7
Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.预防阿尔茨海默病中晚期糖基化终产物受体的激活。
Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210.
8
Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.抑制 RAGE 轴信号:药理学挑战。
Curr Drug Targets. 2019;20(3):340-346. doi: 10.2174/1389450119666180820105956.
9
The RAGE signaling in osteoporosis.骨质疏松症中的 RAGE 信号通路。
Biomed Pharmacother. 2023 Sep;165:115044. doi: 10.1016/j.biopha.2023.115044. Epub 2023 Jun 23.
10
Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.糖基化反应和晚期糖基化终产物受体在免疫和社会行为中的作用。
Glycoconj J. 2021 Jun;38(3):303-310. doi: 10.1007/s10719-020-09956-6. Epub 2020 Oct 27.

引用本文的文献

1
The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?自身抗体在阿尔茨海默病中的作用:致病关联还是附带现象?
Alzheimers Dement. 2025 Jul;21(7):e70484. doi: 10.1002/alz.70484.
2
Evaluation of the Effects of Thymoquinone on RAGE/NOX4 Expressions and Brain Tissue Morphometry in Experimental Alzheimer's Disease Induced by Amyloid Beta 1-42 Peptide.胸腺醌对β-淀粉样蛋白1-42肽诱导的实验性阿尔茨海默病中晚期糖基化终末产物受体/烟酰胺腺嘌呤二核苷酸磷酸氧化酶4表达及脑组织形态测定的影响评估
Biomolecules. 2025 Apr 7;15(4):543. doi: 10.3390/biom15040543.
3
Fructose-mediated AGE-RAGE axis: approaches for mild modulation.

本文引用的文献

1
Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.从羊驼中特异性针对人晚期糖基化终产物受体的纳米抗体的产生、生化特性分析及其验证。
Biochem Biophys Res Commun. 2021 Dec 3;581:38-45. doi: 10.1016/j.bbrc.2021.10.005. Epub 2021 Oct 8.
2
Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.单域抗体透过血脑屏障的转运。
Biomolecules. 2021 Jul 31;11(8):1131. doi: 10.3390/biom11081131.
3
DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
果糖介导的晚期糖基化终产物-晚期糖基化终产物受体轴:轻度调节方法。
Front Nutr. 2024 Dec 4;11:1500375. doi: 10.3389/fnut.2024.1500375. eCollection 2024.
4
Advanced Glycation End Products (AGEs) Webinar Meeting Report.晚期糖基化终末产物(AGEs)网络研讨会会议报告
J Diabetes Sci Technol. 2025 Mar;19(2):576-581. doi: 10.1177/19322968241296541. Epub 2024 Nov 7.
5
Dietary galactose exacerbates autoimmune neuroinflammation advanced glycation end product-mediated neurodegeneration.饮食半乳糖加剧自身免疫性神经炎症和晚期糖基化终产物介导的神经退行性变。
Front Immunol. 2024 Aug 9;15:1367819. doi: 10.3389/fimmu.2024.1367819. eCollection 2024.
6
Specific antagonist of receptor for advanced glycation end‑products attenuates delirium‑like behaviours induced by sevoflurane anaesthesia with surgery in aged mice partially by improving damage to the blood‑brain barrier.晚期糖基化终产物受体特异性拮抗剂可部分通过改善血脑屏障损伤减轻老年小鼠七氟醚麻醉联合手术诱导的谵妄样行为。
Exp Ther Med. 2023 May 15;26(1):317. doi: 10.3892/etm.2023.12016. eCollection 2023 Jul.
针对晚期糖基化终产物受体的 DNA-适体可提高脓毒症小鼠的生存率。
Oxid Med Cell Longev. 2021 Aug 7;2021:9932311. doi: 10.1155/2021/9932311. eCollection 2021.
4
Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.长寿个体中可溶性晚期糖基化终产物受体异构体和晚期糖基化终产物的调节。
Biomark Med. 2021 Aug;15(11):785-796. doi: 10.2217/bmm-2020-0856. Epub 2021 Jul 8.
5
Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 murine model of amyotrophic lateral sclerosis in a sex-dependent manner.小胶质细胞 RAGE 以性别依赖的方式加剧 SOD1 肌萎缩侧索硬化症小鼠模型中的神经退行性变进展。
J Neuroinflammation. 2021 Jun 15;18(1):139. doi: 10.1186/s12974-021-02191-2.
6
RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE/AT1 complex on the cell membrane.RAGE 配体通过细胞膜上的 RAGE/AT1 复合物刺激血管紧张素 II 型 1 型受体 (AT1)。
Sci Rep. 2021 Mar 11;11(1):5759. doi: 10.1038/s41598-021-85312-4.
7
Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis.靶向 RAGE 的衔接蛋白 SLP76 作为治疗致死性脓毒症的一种方法。
Nat Commun. 2021 Jan 12;12(1):308. doi: 10.1038/s41467-020-20577-3.
8
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.评估晚期糖基化终产物及其受体与痴呆风险的关系。
JAMA Netw Open. 2021 Jan 4;4(1):e2033012. doi: 10.1001/jamanetworkopen.2020.33012.
9
The receptor for advanced glycation end products is a sensor for cell-free heme.晚期糖基化终产物受体是无细胞血红素的传感器。
FEBS J. 2021 Jun;288(11):3448-3464. doi: 10.1111/febs.15667. Epub 2020 Dec 29.
10
G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.G82S RAGE 多态性影响阿尔茨海默病病理相关的淀粉样蛋白-RAGE 相互作用。
PLoS One. 2020 Oct 29;15(10):e0225487. doi: 10.1371/journal.pone.0225487. eCollection 2020.